Clinical Trial Update: Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating safety and efficacy of estetrol in postmenopausal women with advanced estrogen receptor-positive breast cancer (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Neoplasms
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Estetrol (estetrol)

Snippet

Sponsor: Pantarhei Oncology B.V. | Conditions: Breast Neoplasms | Phase 1, Phase 2 | Status: COMPLETED